You are here

ACLDT, University of Pittsburgh team up on Singapore transplant center

The Asian American Medical Group Inc. (AAMG), a wholly owned subsidiary of ACLDT, entered into the agreement with the university in which UPMC will provide specialized services needed to set up a comprehensive transplant center while AAMG will spearhead the development of the two organizations’ collaboration in Asia and beyond.

The agreement with UPMC is part of ACLDT’s strategic direction to offer specialized treatment and transplantations for organs other than the liver and to develop a full-fledged comprehensive transplant center in Singapore to serve the pan-Asia and Middle East markets. This new center will specialize in transplant immunology, transplant, infectious diseases and care of immune-suppressed patients.

In line with the development of the comprehensive transplant center, AAMG also plans to establish a center for stem cell and bone marrow transplantation at Gleneagles Hospital under its wholly owned subsidiary, Asian Centre for Blood and Bone Marrow Transplantation Pte Ltd. This center expects to be up and running early next year.

Under the agreement UPMC will assist AAMG in expanding its current capacity to provide clinical services for patients, as well as with clinical and translational research. UPMC and AAMG will collaborate in the planning and design of the center, then UPMC will continue to assist AAMG with its clinical service programs.

Plans call for the eventual establishment of a clinical network throughout Southeast Asia and other countries.

Learn more:
Asian Liver Center